DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD) announced today that Dr. Eric A. Rose has been appointed to its Board of Directors. Dr. Rose is an esteemed cardiothoracic surgeon, having authored or co-authored more than 300 peer-reviewed publications including articles on cardiovascular surgery, ventricular assist devices and cardiac transplantation. Dr. Rose has led the development of a premier Department of Surgery at Columbia University and has managed, investigated, and developed numerous complex medical technologies ranging from heart transplantation to novel approaches to treat Alzheimer’s disease and bioterrorism. He is currently on leave as Chairman of Columbia’s Department of Surgery, a position he held since 1994, and is serving as Chief Executive Officer and Chairman of the board of SIGA Technologies, Inc., a leading biotechnology firm addressing bioterrorist threats.
